Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04981275 · ClinicalTrials.gov registry record

A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype

A clinical trial, sponsored by Onegevity Health.

Completed
Registry status
81
Enrollment target

NCT04981275: Completed study, sponsored by Onegevity Health.

NCT04981275 is a clinical trial that has completed, run by Onegevity Health. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04981275 has completed, sponsored by Onegevity Health.

COMPLETED
Registry status
81 participants
Enrollment target

Study Summary

The purpose of this research study is to explore the relationship between the gut microbiome and hormone levels in women diagnosed with PCOS and determine whether there are differences in the gut microbiome between women with PCOS and women without PCOS. Consented, enrolled participants will complete a health questionnaire, complete a fasted blood draw at a local laboratory, and provide a stool, saliva, and vaginal swab sample for comprehensive biomarkers, hormones, metagenomics, and metabolomics analysis.

Interventions

  • OTHER No intervention study

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2021-06-19
Est. Completion 2023-09-30

Sponsor

Onegevity Health

2 total trials

What the Registry Record Tells You About NCT04981275

The ClinicalTrials.gov registry entry for NCT04981275 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Onegevity Health, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which No intervention study is the first listed.

NCT04981275 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04981275 about?

NCT04981275 is a clinical study titled "A Multi-omic Approach to Evaluate and Characterize the Polycystic Ovary Syndrome (PCOS) Phenotype". The purpose of this research study is to explore the relationship between the gut microbiome and hormone levels in women diagnosed with PCOS and determine whether there are differences in the gut microbiome between women with PCOS and women without PCOS. Consented, enrolled participants will comple...

What is the current status of trial NCT04981275?

This trial is currently completed. The enrollment target is 81 participants. The study started on 2021-06-19. Estimated completion is 2023-09-30.

What interventions are being tested in trial NCT04981275?

The interventions under investigation include: No intervention study (OTHER).

Who is sponsoring clinical trial NCT04981275?

This trial is sponsored by Onegevity Health, which has 2 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.